Anavex Life Sciences (AVXL AVXLD) - my valuation model shows 10-bagger potential My price target for AVXLD is $124 which presents over 1,000% upside (10-bagger). This valuation only considers AVXLD's lead program - their drug Anavex 2-73 for treating Alzheimer's Disease. I used the Times Revenue Multiple Valuation method. Below is my Mo...?